All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date Terminated | 2005-001562-13 | OXCARBAZEPINE VS PHENYTOIN IN THE TREATMENT OF SEIZURES IN PATIENTS WITH BRAIN TUMORS UNDERGOING NEUROSURGICAL PROCEDURES | bad-data | |
| Completed, but no date | 2005-006105-40 | TREATMENT OF IDIOPATHIC ASTHENOZOOSPERMIE WITH COENZYME Q10. A DOUBLE BLIND CONTROLLED STUDY | bad-data | |
| Not reported | 2006-001505-28 | Randomised, parallel phase IV study on the safety of hymenoptera venom immunotherapy | 2008-07-30 | due-trials |
| Not reported | 2006-002564-25 | A PHASE II MULTICENTER STUDY OF BORTEZOMIB, THALIDOMIDE, PEGHILATED LIPOSOMAL DOXORUBICIN, DEXAMETHASONE (ThaDD-V)IN PATIENTS AFFECTED BY RELAPSED-REFRACTORY MULTIPLE MYELOMA | 2009-07-20 | due-trials |
| Not reported | 2006-002588-22 | A phase II, multicenter study of etoposide, aracytin, dexamethasone and bortezomib in patients affected by relapsed/refractory multiple myeloma previously treated with thalidomide | 2008-10-20 | due-trials |
| Ongoing | 2006-003957-25 | Rare Diseases with microvascular involvement. High Dose Intravenous N-acetylcysteine versus Iloprost for early, rapidly progressive diffuse Systemic Sclerosis (Scleroderma) | not-yet-due | |
| Ongoing | 2006-004016-40 | APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER | not-yet-due | |
| Ongoing | 2006-005757-30 | MIRACL IN CABG - Statins in cardiac surgery. Effect of doses on inflammatory response and early results | not-yet-due | |
| Ongoing | 2007-005322-68 | Low-dose oral imatinib in the treatment of scleroderma pulmonary involvement: a phase II pilot study | not-yet-due | |
| Ongoing | 2008-004996-24 | A RANDOMIZED PHASE II STUDY OF TAXOTERE, OXALIPLATIN, CAPECITABINE (TOX) OR EPIDOXORUBICIN, OXALIPLATIN AND CAPECITABINE (EOX) IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC CANC... | not-yet-due | |
| Ongoing | 2008-005967-33 | randomized phase II trial of two different sequences in first line chemotherapy of advanced non small cell lung cancer | not-yet-due | |
| Completed, but no date | 2009-012317-22 | PEDIATRIC BASAL BOLUS THERAPY - Basal-Bolus regimen in the treatment of children with type 1 diabetes | bad-data | |
| Other | 2009-016902-17 | Direct renin inhibitor (aliskiren)and carotid plaques instability markers in hypertensive patients requiring carotid endoarterectomy | not-yet-due | |
| Completed, but no date | 2009-017412-32 | RANDOMISED CONTROLLED TRIAL OF BOTULINUM TOXIN TYPE A AND B EFFICACY IN REDUCING DROOLING IN PARKINSON DISEASE | bad-data | |
| Ongoing | 2010-020072-33 | Bendamustine, Bortezomib and Dexamethasone (BVD) in the treatment of relapsed or refractory Multiple Myeloma | not-yet-due | |
| Ongoing | 2012-000477-23 | A randomized phase II study of FOLFORI plus or not CETUXIMAB in elderly advanced colorectal cancer patients. Studio randomizatto di fase II con FOLFIRI piu' CETUXIMAB o FOLFIRI da solo in pazienti ... | not-yet-due | |
| Ongoing | 2012-004742-16 | Evaluation of the risk of nephrotoxicity caused by the intravenous administration of nonionic iodinated contrast media Valutazione del rischio della nefrotossicita' conseguente alla somministrazio... | not-yet-due | |
| Ongoing | 2013-004596-12 | HOME INFUSION THERAPY WITH ILOPROST USING A PORTABLE SYRINGE PUMP FOR THE TREATMENT OF PERIPHERAL ULCERS AND RAYNAUD'S PHENOMENON IN SYSTEMIC SCLEROSIS. SOMMINISTRAZIONE DOMICILIARE DI ILOPROST ... | not-yet-due | |
| Ongoing | 2018-004946-41 | Personalized Versus Standardized Parenteral Nutrition for Preterm Infants With a Birth Weight Greater Than 1250 Grams: a Multicenter Randomized Phase IV Clinical Trial Nutrizione parenterale person... | not-yet-due | |
| Ongoing | 2019-002923-13 | Indication for the exougenous surfactant administration to treat neonatal respiratory distress syndrome in the preterm infant: a single-center randomized phase 4 trial based on the comparison of two l... | not-yet-due | |
| Ongoing | 2020-002035-30 | TOFAcitinib plus Hydroxycloroquine vs Hydroxycloroquine in patients with early onset SARS-CoV2 (COVID-19) interstitial pneumonia: a multicenter randomized controlled open label trial Tofacitinib as... | not-yet-due |